Name

Optima Pharmaceutical

Legal name

Optima Pharmazeutische GmbH

Website

https://optimapharma.de

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Ophthalmic & ENT Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Pharmaceutical and Medicine Manufacturing (3254), Optical Goods Retailers (45613)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Ophthalmology Pharmaceuticals (HLAIAAAL)

akta.pro secondary industries

Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Liposomal medical devices
• Dry eye treatment
• Ophthalmology products
• Ear and nasal care
• Private label pharmaceuticals

Headquarters

HQ city

Hallbergmoos

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Branded Medical Device Sales: Sale of proprietary branded medical devices under product brands including Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, and others across ophthalmology, ENT, and pulmonology segments.
2. Private Label / OEM Licensing: In-licensing and private label manufacturing agreements where Optima provides its formulations and manufacturing expertise to partners for distribution under partner brand names. Revenue generated through licensing fees and product supply.
3. Direct Consumer Sales (E-commerce): Products available for purchase directly via Amazon and pharmacy ordering links on product pages, suggesting direct-to-consumer and e-commerce retail channels.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Optima Pharmaceutical develops, manufactures, and distributes a portfolio of preservative-free, liposomal medical devices focused on ophthalmology (especially dry eye and eyelid care), ENT (ear and nasal care), and pulmonology/dry-mouth applications. The company sells its products under its own brands — Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, tima-oculav, and others — through pharmacies, opticians, hearing-care specialists, and Amazon, while also offering in-licensing and private-label (OEM) manufacturing partnerships to pharmaceutical and medical device distributors across Europe, Australia, New Zealand, and Canada.

Product overview

Optima Pharmaceutical is an owner-managed, medium-sized family business that develops, manufactures, and distributes innovative medical devices. The company operates in three therapeutic areas: ophthalmology (the core competency, particularly for dry eye syndrome treatment), ear, nose and throat medicine (ENT), and pulmonology. The product portfolio includes Tears Again (liposomal eye spray and eye drops for dry eyes), BlephaCura (eyelid care products), LipoNit (comprehensive dry eye management line including eye sprays, hyaluronic acid drops, eyelid care products, and warming masks), tima-oculav (sterile phosphate buffer eye wash for chemical burns), OtoCura (ear spray for earwax management and ear canal care), LipoNasal (liposomal nasal spray for sinus and allergy relief), LipoSaliva (mouth spray for dry mouth/xerostomia), and LipoAerosol (respiratory care). The company also offers in-licensing and private label solutions to partners, with products distributed in over 20 countries through branded and private label solutions.

Differentiator

Problem solved

Functional benefit

Brands

• TEARS AGAIN: Liposomal eye spray and eye drops for dry eye treatment.
• Lipo Nit
• LipoNasal
• OtoCura
• tima-oculav
• BlephaCura
• Isogutt
• Lento Nit K
• LipoAerosol
• LipoSaliva
• Nozovent

Products and services

• Tears Again Liposomal eye spray and eye drops that stabilize the protective lipid layer of the tear film and gently moisturize all forms of dry eye, intended for adult consumers and recommended for screen work, air-conditioned environments, and contact lens wear.
• Lipo Nit Product line including liposomal eye sprays that stabilize and protect the tear film, hyaluronic acid eye drops, eyelid care fluid, eyelid hygiene wipes, and a warming gel mask — used for full dry eye management and sold exclusively via opticians and hearing care professional shops.
• BlephaCura Daily eyelid care and lid margin hygiene products for managing blepharitis (eyelid inflammation), dry, irritated, and sensitive eyes, supporting the natural function of the meibomian glands across warming and cleansing steps.
• tima-oculav Sterile phosphate-buffer eye wash for first aid after chemical burns, chemically neutralizing H+ or OH- ions from acids or alkalis and requiring significantly less volume than water; a single-use medical device for emergency eye flushing.
• OtoCura Ear spray that supports the ear's natural self-cleaning by gently softening and loosening earwax (cerumen) while protecting sensitive ear canal skin with a conditioning blend of olive, almond, and calendula oils; also improves comfort for hearing aid and in-ear headphone users.
• LipoNasal Liposomal nasal spray with dexpanthenol that moisturizes nasal and sinus mucous membranes, supports natural protective and clearance functions, relieves chronic sinusitis and allergic rhinitis symptoms, and uses phospholipid liposomes that physically interact with respiratory viruses.
• LipoSaliva Liposomal oral spray containing phospholipids for long-lasting moistening and care of oral and throat mucous membranes in patients with dry mouth (xerostomia), suitable for medication-, radiation-, or CPAP/oxygen-therapy-induced dryness and clinically proven to improve discomfort and taste disorders.
• LipoAerosol Respiratory care product line for treating irritative cough, laryngitis, and tracheotomy care, designed to support and moisten irritated airways.
• Isogutt Eye drop product line for acute treatment of irritated ocular mucous membranes.
• Lento Nit K Ophthalmology product line for eye care and dry eye management, complementing the Lipo Nit range of sprays, drops, and eyelid-care products.
• Nozovent Nasal device product for nasal care and breathing support.
• Otovent Ear pressure equalization device used to relieve ear pain when flying and diving by equalizing pressure in the middle ear.
• In-Licensing and Private Label (OEM) Partnerships B2B offering in which Optima provides its proprietary liposomal formulations, regulatory documentation, and manufacturing expertise to pharmaceutical and medical device distributors for in-licensing or private-label distribution under partner brand names across the ophthalmology, ENT, and pulmonology categories.

Quantifiable outcome

• Products successfully distributed in 20+ countries
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• World VisioncoreStrategic or Co-development Partner · 1 January 2019Optima has been supporting World Vision since 2019 in disseminating the FMNR (Farmer Managed Natural Regeneration) method, developed by Tony Rinaudo (Right Livelihood Award winner). Regenerative reforestation projects in Kenya, Senegal, Ghana, and Uganda focus on climate protection, fighting desertification, hunger, and poverty by improving crop yields.
• Plant-for-the-PlanetminorOthersOptima facilitates tree planting through the Plant-for-the-Planet organization as part of its climate neutrality and reforestation commitment.
• Bergwaldprojekt eVminorOthersOptima supports tree planting through Bergwaldprojekt eV as part of its sustainability commitment. Over 100,000 trees have been facilitated through this and Plant-for-the-Planet partnerships.
• DFGE (Institute for Energy, Ecology and Economy)coreStrategic or Co-development PartnerDFGE provides annual Corporate Carbon Footprint calculations for the Optima Group, covering Scope 1, 2, and 3 emissions. DFGE also issues the climate neutrality certification for the company. This partnership is central to Optima's climate neutrality strategy, first certified in 2014.
• German Society of Ophthalmology (DOG)coreStrategic or Co-development PartnerOptima has been the exclusive sponsor of the DOG Science Award for Dry Eye and Blepharitis/MGD since 2014, awarded annually in cooperation with the Professional Association of German Ophthalmologists (BVA). This research award supports outstanding clinical and basic scientific work in dry eye and meibomian gland dysfunction.
• Professional Association of German Ophthalmologists (BVA)coreStrategic or Co-development PartnerJoint sponsor with DOG of the annual DOG Science Award for Dry Eye and Blepharitis/MGD, supported by Optima Pharmazeutische GmbH. Awards outstanding research in ophthalmology and dry eye disease since 2014.
• United Nations Global CompactcoreStrategic or Co-development PartnerOptima joined the UN Global Compact in 2014, committing to ten universally recognized principles in human rights, labour standards, environmental protection, and anti-corruption. The company publishes annual sustainability reports on the UN Global Compact website.
• Circius Pharma ABminorChannel Partner/ Reseller/ DistributorApplication images for Otovent (ear pressure regulation device for flying and diving) are sourced from Circius Pharma AB, suggesting a product/image licensing or distribution relationship.
• DermatestminorOthersOtoCura ear spray was independently tested and awarded the 'VERY GOOD' rating by Dermatest in June 2025, providing third-party dermatological certification of skin compatibility and safe use.
• 40+ Distribution Partners (Europe, Australia, New Zealand, Canada)coreChannel Partner/ Reseller/ DistributorOptima maintains a network of 40+ distribution partners across Europe, Australia, New Zealand, and Canada. Products are sold in more than 20 countries under both branded products and private label solutions through these partnerships.

Scale indicators3 records

Recent moves4 records

Expansion highlights6 records

Broad incumbents

• Rohto Pharmaceutical Co., Ltd. Japanese OTC eye care leader (Rohto V, Mentholatum) with broad dry eye, lid, and contact lens comfort products globally. Comparable OTC ophthalmic portfolio but a much larger international consumer health player than Optima.
• Alcon Inc. Largest dedicated eye-care company globally with pharma, surgical, and OTC vision care (e.g., Systane, OPTI-FREE). Comparable in ophthalmic medical device and dry-eye category but operating at vastly greater scale.
• Santen Pharmaceutical Co., Ltd. Japan-headquartered global specialty ophthalmology company with deep dry eye, glaucoma, and ocular surgery franchises (including preservative-free formulations comparable to Tears Again). Comparable therapeutic focus, larger scale and global reach than Optima.
• Bausch + Lomb (Bausch Health): Global eye-health company with broad OTC dry eye, lid hygiene (Soothe, Blink), and ophthalmology portfolios distributed through pharmacy and ECP channels. Comparable in product categories but vastly larger scale than Optima.

Emerging players

• Novaliq GmbH: Heidelberg-based clinical-stage ophthalmology company developing water-free (EyeSol) therapies for dry eye and other ocular surface diseases. Comparable as a German/Spanish ophthalmology innovator working on novel tear-film chemistry, though focused on Rx versus Optima's OTC/device positioning.

Direct peers

• Croma-Pharma GmbH: Austrian family-owned company specializing in ophthalmology (surgical, intraocular lenses, eye drops) and aesthetic medicine. Comparable as a DACH-region specialty ophthalmology company with overlapping lid and ocular surface product categories.
• Ursapharm Arzneimittel GmbH: German family-owned pharmaceutical/medical device company focused on ophthalmology, ENT, and related specialty areas (e.g., hyaluronic acid eye drops, nasal sprays). Closely comparable to Optima in geography, therapeutic mix, Mittelstand structure, and OTC/pharmacy distribution orientation.
• Laboratoires Théa: Independent French ophthalmology specialty company with a leading preservative-free dry eye, lid hygiene, and ocular surface portfolio distributed across Europe. Highly comparable to Optima in independent specialty-pharma positioning, preservative-free medical device focus, and European partnership-driven GTM.
• OmniVision GmbH: German specialist in ophthalmic products including eye drops, lid care, and contact lens solutions. Directly comparable as a same-size German Mittelstand competitor in preservative-free eye drops and eyelid hygiene.
• Similasan AG: Switzerland-based OTC ophthalmology/ENT specialist selling preservative-free eye drops, ear, and sinus products via pharmacy channels in Europe and North America. Similar independent, mid-sized specialty positioning to Optima with comparable distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Optima Pharmaceutical